HMG20B anticorps (AA 31-50)

N° du produit ABIN636227

Détail du produit anti-HMG20B anticorps

Antigène: HMG20B (High Mobility Group 20B (HMG20B))

Épitope: AA 31-50

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp HMG20B est non-conjugé

Application: Western Blotting (WB)

Réactivité croisée (Details): This antibodys immunogens shares 80 % sequence identity with its Mouse homolog.

Purification: Affinity chromatography purified

Immunogène: BRAF35 antibody was raised in rabbit using AA 31-50 [KQERGEGPRA GEKGSHEEEP] of the human structural DNA-binding protein BRAF35 as the immunogen.

Isotype: IgG

Information d'application

Indications d'application: WB: 1:500-1:1,000
Optimal conditions should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Concentration: Lot specific

Buffer: Affinity purified IgG supplied in PBS with 0.02 % NaN3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.

Détails sur HMG20B

Antigène: HMG20B (High Mobility Group 20B (HMG20B))

Autre désignation: BRAF35 (HMG20B Produits)

Synonymes: anticorps BRAF25, anticorps BRAF35, anticorps HMGX2, anticorps HMGXB2, anticorps PP7706, anticorps SMARCE1r, anticorps SOXL, anticorps pp8857, anticorps AW610687, anticorps Hmgx2, anticorps Hmgxb2, anticorps Smarce1r, anticorps high mobility group 20 B, anticorps high mobility group 20B, anticorps Hmg20b, anticorps HMG20B

Sujet: Mutations of the human BRCA2 gene confer susceptibility to breast cancer. A structural DNA binding component has been identified and is designated as BRCA2-Associated Factor 35 (BRAF35). There is a close association of the BRAF35/BRCA2 complex with condensed chromatin coincident with histone H3 phosphorylation. Experimental evidence suggests a role for the BRCA2/BRAF35 complex in the modulation of cell cycle progression.